We analyzed the correlation between the number of genetic mutations or oncogenic mutations and clinicopathological characteristics, such as age, sex, tumor site, Ki-67 proliferation index, Eastern Cooperative Oncology Group (ECOG) score, B symptoms, International Prognostic Index (IPI), tumor stage and molecular subtype. This evidence concerns the gene MKI67 and neoplasm.